Monomeric CRP regulates inflammatory responses in human intervertebral disc cells. Issue 3 (8th March 2023)

• Record Type: Journal Article
• Authors: Ruiz-Fernández, Clara; Ait Eldjoudi, Djedjiga; González-Rodríguez, Maria; Cordero Barreal, Alfonso; Farrag, Yousof; García-Caballero, Lucia; Lago, Francisca; Mobasheri, Ali; Sakai, Daisuke; Pino, Jesús; Gualillo, Oreste
• Is Part Of: Bone & joint research. Volume 12:Issue 3(2023)
• Page Start: 189
• Page End: 198
• Publication Date: 2023-03-08
• Subjects: Musculoskeletal system -- Periodicals; 573.705
• DOI: 10.1302/2046-3758.123.BJR-2022-0223.R1
• Languages: English
• ISSNs: 2046-3758

Abstract

Abstract : Aims: CRP is an acute-phase protein that is used as a biomarker to follow severity and progression in infectious and inflammatory diseases. Its pathophysiological mechanisms of action are still poorly defined. CRP in its pentameric form exhibits weak anti-inflammatory activity. The monomeric isoform (mCRP) exerts potent proinflammatory properties in chondrocytes, endothelial cells, and leucocytes. No data exist regarding mCRP effects in human intervertebral disc (IVD) cells. This work aimed to verify the pathophysiological relevance of mCRP in the aetiology and/or progression of IVD degeneration. Methods: We investigated the effects of mCRP and the signalling pathways that are involved in cultured human primary annulus fibrosus (AF) cells and in the human nucleus pulposus (NP) immortalized cell line HNPSV-1. We determined messenger RNA (mRNA) and protein levels of relevant factors involved in inflammatory responses, by quantitative real-time polymerase chain reaction (RT-qPCR) and western blot. We also studied the presence of mCRP in human AF and NP tissues by immunohistochemistry. Results: We demonstrated that mCRP increases nitric oxide synthase 2 (NOS2), cyclooxygenase 2 (COX2), matrix metalloproteinase 13 (MMP13), vascular cell adhesion molecule 1 (VCAM1), interleukin (IL)-6, IL-8, and Lipocalin 2 (LCN2) expression in human AF and NP cells. We also showed that nuclear factor-κβ (NF-κβ), extracellular signal-regulated kinase 1/2 (ERK1/2), and phosphoinositide 3-kinase (PI3K) are at play in the intracellular signalling of mCRP. Finally, we demonstrated the presence of mCRP in human AF and NP tissues. Conclusion: Our results indicate, for the first time, that mCRP can be localized in IVD tissues, where it triggers a proinflammatory and catabolic state in degenerative and healthy IVD cells, and that NF-κβ signalling may be implicated in the mediation of this mCRP-induced state. Cite this article: Bone Joint Res 2023;12(3):189–198.